Protein kinase inhibitors as targeted therapy for glioblastoma: a meta-analysis of randomized controlled clinical trials by José Pinto-Fraga, Celia García-Chico, Simone Lista, Pedro Miguel Lacal, Giuseppe Carpenzano, Maurizio Salvati, Alejandro Santos-Lozano, Grazia Graziani, Claudia Ceci

Subjects: Get full text

The FGFR inhibitor Rogaratinib reduces microglia reactivity and synaptic loss in TBI by Rida Rehman, Rida Rehman, Albrecht Froehlich, Florian olde Heuvel, Lobna Elsayed, Tobias Boeckers, Tobias Boeckers, Markus Huber-Lang, Cristina Morganti-Kossmann, Cristina Morganti-Kossmann, Francesco Roselli, Francesco Roselli

Subjects: Get full text

Predictive value of direct bilirubin and total bile acid in lung adenocarcinoma patients treated with EGFR-TKIs by Yuting Li, Bicheng Wang, Shihong Fei, You Qin

Subjects: “…Epidermal growth factor receptor-tyrosine kinase inhibitor…”
Get full text

Glioblastoma tümörlerinde çoklu ilaç direnci by Selim Uzunoğlu, Harika Atmaca, Emir Bozkurt

Subjects: Get full text

Diffuse pediatric high-grade glioma of methylation-based RTK2A and RTK2B subclasses present distinct radiological and histomolecular features including Gliomatosis cerebri phenotyp... by Arnault Tauziède-Espariat, Lea L. Friker, Gunther Nussbaumer, Brigitte Bison, Volodia Dangouloff-Ros, Alice Métais, David Sumerauer, Josef Zamecnik, Martin Benesch, Thomas Perwein, Dannis van Vuurden, Pieter Wesseling, Andrés Morales La Madrid, Maria Luisa Garrè, Manila Antonelli, Felice Giangaspero, Torsten Pietsch, Dominik Sturm, David T. W. Jones, Stefan M. Pfister, Yura Grabovska, Alan Mackay, Chris Jones, Jacques Grill, Yassine Ajlil, André O. von Bueren, Michael Karremann, Marion Hoffmann, Christof M. Kramm, Robert Kwiecien, David Castel, Gerrit H. Gielen, Pascale Varlet

Subjects: “…Receptor tyrosine kinase…”
Get full text

Significance of Runt-related transcription factor 1 and Notch1 expression in non-small-cell lung cancer: involvement in epithelial-mesenchymal transition and epidermal growth facto... by Heba M Rashad, Hanan Ahmed, Samar N Mohamed, Hiam A. Eleleimy, Ebtehal M Abdel-Aal

Subjects: “…epidermal growth factor receptor–tyrosine kinase inhibitor; epithelial–mesenchymal transition; notch1; runt-related transcription factor1…”
Get full text

Shikonin induces the apoptosis and pyroptosis of EGFR-T790M-mutant drug-resistant non-small cell lung cancer cells via the degradation of cyclooxygenase-2 by Shaoyi Cao, Huaqiu Li, Xiaoyan Ye, Xinxing Xing, Yonghuan Xie, Xiangfeng Zeng, Hongjiao Liu, Xing Zhong, Xinyi Yang, Wenxiu Xing, Cairong Zhu, Xiaoping Wu

Subjects: “…Epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) resistance…”
Get full text

Discovery of novel and potent dual-targeting AXL/HDAC2 inhibitors for colorectal cancer treatment via structure-based pharmacophore modelling, virtual screening, and molecular dock... by Xiao Qiao, Xiangyu Wu, Shutong Chen, Miao-Miao Niu, Huilian Hua, Yan Zhang

Subjects: Get full text

Prolonged survival in postoperative recurrent EGFR-L858R NSCLC: A 24-year case report by Yoshihiro Go, Chinatsu Yoshizaki, Yuki Yoshida, Shiho Nohmi, Rui Kusakado, Yuichiro Saito, Kensuke Izumizaki, Takafumi Ogawa, Takashi Suzuki, Fumihiro Yamaguchi

Subjects: “…Epidermal growth factor receptor-tyrosine kinase inhibitor…”
Get full text

Revolutionizing NSCLC Treatment: Immunotherapy Strategies for EGFR‐TKIs Resistance by Jin Tian, Zhiqi Shi, Lili Zhao, Peng Liu, Xiaojun Sun, Lin Long, Jianhua Zang, Jun Xiao

Subjects: “…epidermal growth factor receptor tyrosine kinase inhibitor (EGFR‐TKI)…”
Get full text

Effectiveness of systemic treatments for advanced non-clear cell renal cell carcinoma: a systematic review and meta-analysis by Yaping Zhang, Jian Chen, Xiaoyan Wang, Hui Wang, Xiaoli Chen, Jianfeng Hong, Hongming Fang

Subjects: “…vascular endothelial growth factor receptor tyrosine kinase inhibitors…”
Get full text